Effect of timing of palliative care on outcomes for patients with advanced cancer

the ONA take:

The efficacy of integrated oncology and palliative care (PC) are supported by randomized controlled trials; however, optimal timing of initiation of these services has not been evaluated.

In this study, researchers investigated the effect of early versus delayed palliative care on quality of life, symptom impact, mood, 1-year survival, and resource use.

Participants were 207 patients with advanced cancer at a National Cancer Institute cancer center, a Veterans Affairs Medical Center, and community outreach clinics, enrolled between October 2010 and March 2013.

They randomly received an in-person PC consultation, structured PC telehealth nurse coaching sessions (once per week for six sessions), and monthly follow-up either early after enrollment or 3 months later.

Patient-reported outcomes and resource use were not statistically different among the early-entry participants; however, their survival 1 year after enrollment was improved compared with those who began PC later.

Further understanding of how palliative care may improve survival remains an important research priority.

Effect of timing of palliative care on outcomes for patients with advanced cancer
The efficacy of integrated oncology and palliative care are supported by randomized controlled trials.
Early-entry participants' patient-reported outcomes and resource use were not statistically different; however, their survival 1-year after enrollment was improved compared with those who began 3 months later.
READ FULL ARTICLE From Ascopubs
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs